Related Experiment Video
Updated: Jan 26, 2026

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
Published on: October 29, 2019
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease.
Davide Di Fusco1, Vincenzo Dinallo1, Irene Marafini1
1Department of Systems Medicine, Gastroenterology, University of Tor Vergata, Rome, Italy.
Antisense technology offers a precise method to regulate gene expression for treating inflammatory diseases. This review explores oligonucleotide therapeutics for inflammatory bowel diseases (IBD), including Crohn
Area of Science:
- Molecular biology
- Genetics
- Immunology
Background:
- Inflammatory and neoplastic diseases are targeted by novel gene expression regulation technologies.
- Antisense technology inhibits gene expression by targeting cellular RNAs.
- Understanding molecular mechanisms in inflammatory bowel diseases (IBD) like Crohn's disease (CD) and ulcerative colitis (UC) reveals new therapeutic targets.
Purpose of the Study:
- To provide a comprehensive understanding of oligonucleotide therapeutics.
- To review pre-clinical and clinical data on oligonucleotide-based therapy for IBD.
Main Methods:
- Review of scientific literature on antisense technology and oligonucleotide therapeutics.
- Analysis of pre-clinical and clinical data for IBD treatment.
Main Results:
- Antisense technology is a specific and rapid method for gene expression inhibition.
- Advances in IBD molecular mechanisms have identified new therapeutic targets.
- Oligonucleotide therapeutics show promise for IBD treatment.
Conclusions:
- Oligonucleotide therapeutics represent a promising strategy for managing inflammatory bowel diseases.
- Further research and clinical application of these therapies are warranted.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Basic Concept
Length, which measures the distance traveled by an object, is a fundamental concept in engineering mechanics. We use coordinates relative to a reference point to describe the distance. Length not only helps to describe the...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

